Nuo Therapeutics
Highly Engaged Employees
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8285 El Rio St Ste 190, Houston, Texas, ...Phone Number
(346) 396-4770Website
www.nuot.comRevenue
<$5 MillionStock Symbol
AURXIndustry
About Nuo Therapeutics
Nuo Therapeutics Org Chart
Is Nuo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nuo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Nuo Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Nuo Therapeutics launches new products
Check if Nuo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Nuo Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Nuo Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Nuo Therapeutics
Funding: Get notified immidiatlly once Nuo Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Nuo Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Nuo Therapeutics
Compare insights from companies similar to Nuo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuo Therapeutics.
Nuo Therapeutics financials insights
Gather financial insights about Nuo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$1.3M
Debt
$3M
Share Placement
$651K
Private Equity
$792K
Nuo Therapeutics Tech Stack
A closer look at the technologies used by Nuo Therapeutics
Most Recent Scoops
Nuo Therapeutics News & Media
Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
Aurix Product Exhibiting Strong Market Growth Aurix Product Exhibiting Strong Market GrowthNuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate chronic wound healing. A multi-year exclusive agreement between PAM Health and Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company at the forefront of biodynamic therapies, means Nuo’s Aurix System will serve as the sole platelet-rich plasma (PRP) wound care therapy aNuo Therapeutics Provides Corporate and Business Update
Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuo Therapeutics
Nuo Therapeutics, Inc. (the "Company" or "Nuo") is a biomedical company that pioneers leading-edge biodynamic therapies for wound care. The Company's flagship product, Aurix is a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of a variety of wounds.... Read More